WPRIM Management System> DCMS> Chinese Journal of Clinical Oncology> 2019> 46> 14

Volume: 46 Issue: 14

1. Advances in the treatment of patients with stageⅡ-ⅢA non-small cell lung cancer and the EGFR mutation Page:707—711
2. Expression and function of lncRNA BDNF-AS in breast cancer Page:712—717
3. Expression and mechanism of microRNA-613 in breast cancer Page:718—722
4. Expression and potential role of ajuba LIM protein in oral squamous cell carcinoma Page:723—727
5. Clinicopathological characteristics and prognostic factors of 83 patients with ovarian metastasis from gastric cancer Page:728—733
6. A combination of lenalidomide, bortezomib, and dexamethasone (RVD) provides deep-er responses in patients with newly diagnosed multiple myeloma Page:734—738
7. Efficacy and safety of PEG-rhG-CSF therapy in the primary and secondary prevention of chemotherapy-induced neutropenia Page:739—744
8. Research advances of tRNA-derived fragments in tumors Page:745—749
9. Clinical management of common adverse effects of ibrutinib Page:750—754
10. Homing barriers and solutions for CAR-T cells in the treatment of solid tumors Page:755—759

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.